Ontify
⌘
S
⌘
S
A Study of a Candidate COVID-19 Vaccine (COV001) - Ontify
Share
A Study of a Candidate COVID-19 Vaccine (COV001)
Clinical trial.
Statements about
A Study of a Candidate COVID-19 Vaccine (COV001)
Country
United Kingdom
Instance Of
Clinical Trial
Start Time
March 2020
End Time
May 2021
Number of Participants
510
Title
A Phase I/II Study to Determine Efficacy, Safety and Immunogenicity of the Candidate Coronavirus Disease (COVID-19) Vaccine ChAdOx1 nCoV-19 in UK Healthy Adult Volunteers
Maximum Age
55 year
Main Subject
COVID-19
AZD1222
Wikidata